Schonfeld Strategic Advisors’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-275,390
| Closed | -$71.4K | – | 2034 |
|
|
2025
Q1 | $71.4K | Sell |
275,390
-57,910
| -17% | -$15K | ﹤0.01% | 1924 |
|
|
2024
Q4 | $188K | Sell |
333,300
-210,000
| -39% | -$118K | ﹤0.01% | 1703 |
|
|
2024
Q3 | $326K | Buy |
543,300
+156,900
| +41% | +$94.1K | ﹤0.01% | 1476 |
|
|
2024
Q2 | $1.04M | Buy |
386,400
+209,969
| +119% | +$567K | 0.01% | 1069 |
|
|
2024
Q1 | $905K | Buy |
176,431
+162,331
| +1,151% | +$833K | 0.01% | 1103 |
|
|
2023
Q4 | $7.57K | Sell |
14,100
-3,100
| -18% | -$1.67K | ﹤0.01% | 1623 |
|
|
2023
Q3 | $11.4K | Sell |
17,200
-116,900
| -87% | -$77.5K | ﹤0.01% | 1435 |
|
|
2023
Q2 | $204K | Buy |
+134,100
| New | +$204K | ﹤0.01% | 1496 |
|
|
2021
Q4 | – | Sell |
-18,044
| Closed | -$141K | – | 2071 |
|
|
2021
Q3 | $141K | Sell |
18,044
-7,656
| -30% | -$59.8K | ﹤0.01% | 1779 |
|
|
2021
Q2 | $349K | Buy |
+25,700
| New | +$349K | ﹤0.01% | 1335 |
|